| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alternative splicing of Mff regulates AMPK-mediated phosphorylation, mitochondrial fission and antiviral response
|
Hanada, Yuki
|
|
|
209 |
C |
p.
|
article
|
| 2 |
β-amyloid’s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review
|
O’Connell, Aoife
|
|
|
209 |
C |
p.
|
article
|
| 3 |
An in-depth look at the relationship between anti-diabetic drugs and Alzheimer’s disease
|
Huang, Shiyi
|
|
|
209 |
C |
p.
|
article
|
| 4 |
Antifungal properties of abnormal cannabinoid derivatives: Disruption of biofilm formation and gene expression in Candida species
|
Ofori, Prince
|
|
|
209 |
C |
p.
|
article
|
| 5 |
β-asarone protects against age-related motor decline via activation of SKN-1/Nrf2 and subsequent induction of GST-4
|
Lei, Ming
|
|
|
209 |
C |
p.
|
article
|
| 6 |
Astrocyte-derived lactoferrin inhibits neuronal ferroptosis by reducing iron content and GPX4 degradation in APP/PS1 transgenic mice
|
Fan, Yong-Gang
|
|
|
209 |
C |
p.
|
article
|
| 7 |
Baseline gut microbiome as a predictive biomarker of response to probiotic adjuvant treatment in gout management
|
Zhao, Feiyan
|
|
|
209 |
C |
p.
|
article
|
| 8 |
Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burden
|
Lowe, Vanessa J.
|
|
|
209 |
C |
p.
|
article
|
| 9 |
Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis”
|
Li, Kaiqing
|
|
|
209 |
C |
p.
|
article
|
| 10 |
Commentary on “Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke”
|
Kannan, Raja
|
|
|
209 |
C |
p.
|
article
|
| 11 |
Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944]
|
Chen, Delong
|
|
|
209 |
C |
p.
|
article
|
| 12 |
Corrigendum to “Dynamic regulation of phosphorylation of NMDA receptor GluN2B subunit tyrosine residues mediates ketamine rapid antidepressant effects” [Pharmacol. Res. 205(2024)107236]
|
Wang, Ke
|
|
|
209 |
C |
p.
|
article
|
| 13 |
Corrigendum to “Human F-ATP synthase as a drug target” [Pharmacol. Res. 209 (2024) 107423]
|
Gerle, Christoph
|
|
|
209 |
C |
p.
|
article
|
| 14 |
Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer
|
Hao, Jie
|
|
|
209 |
C |
p.
|
article
|
| 15 |
Developing patient-derived organoids to demonstrate JX24120 inhibits SAMe synthesis in endometrial cancer by targeting MAT2B
|
Zhang, Chunxue
|
|
|
209 |
C |
p.
|
article
|
| 16 |
Editorial Board
|
|
|
|
209 |
C |
p.
|
article
|
| 17 |
Editorial – New European ESH and ESC guidelines for the management of hypertension: More similarities than differences
|
Grassi, Guido
|
|
|
209 |
C |
p.
|
article
|
| 18 |
Efficacy of medications for the treatment of alcohol use disorder (AUD): A systematic review and meta-analysis considering baseline AUD severity
|
Agabio, Roberta
|
|
|
209 |
C |
p.
|
article
|
| 19 |
Enhanced drug classification using machine learning with multiplexed cardiac contractility assays
|
Aghavali, Reza
|
|
|
209 |
C |
p.
|
article
|
| 20 |
ESC-sEVs alleviate non-early-stage osteoarthritis progression by rejuvenating senescent chondrocytes via FOXO1A-autophagy axis but not inducing apoptosis
|
Feng, Kai
|
|
|
209 |
C |
p.
|
article
|
| 21 |
Excessive alcohol intake produces persistent mechanical allodynia and dysregulates the endocannabinoid system in the lumbar dorsal root ganglia of genetically-selected Marchigian Sardinian alcohol-preferring rats
|
Borgonetti, Vittoria
|
|
|
209 |
C |
p.
|
article
|
| 22 |
Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers
|
Cheng, Le
|
|
|
209 |
C |
p.
|
article
|
| 23 |
Ex vivo fluorescence-guided resection margin assessment in breast cancer surgery using a topically applied, cathepsin-activatable imaging agent
|
Linders, Daan G.J.
|
|
|
209 |
C |
p.
|
article
|
| 24 |
Flavonoids and their derivatives as DNA topoisomerase inhibitors with anti-cancer activity in various cell models: Exploring a novel mode of action
|
Sitarek, Przemysław
|
|
|
209 |
C |
p.
|
article
|
| 25 |
Flavonoids, gut microbiota and cardiovascular disease: Dynamics and interplay
|
Mansour, Hadi
|
|
|
209 |
C |
p.
|
article
|
| 26 |
From exosomes to mitochondria and myocardial infarction: Molecular insight and therapeutic challenge
|
Liu, Chang
|
|
|
209 |
C |
p.
|
article
|
| 27 |
GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson’s disease animal models
|
Ha, Tae-Young
|
|
|
209 |
C |
p.
|
article
|
| 28 |
Gut microbiota-driven metabolic alterations reveal the distinct pathogenicity of chemotherapy-induced cachexia in gastric cancer
|
Wu, Jian
|
|
|
209 |
C |
p.
|
article
|
| 29 |
Harnessing natural inhibitors of protein synthesis for cancer therapy: A comprehensive review
|
Liu, Liqin
|
|
|
209 |
C |
p.
|
article
|
| 30 |
Human F-ATP synthase as a drug target
|
Gerle, Christoph
|
|
|
209 |
C |
p.
|
article
|
| 31 |
Identification of the TRPA1 cannabinoid-binding site
|
Amawi, Tala
|
|
|
209 |
C |
p.
|
article
|
| 32 |
Impact of Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease
|
Yen, Ju-Ching
|
|
|
209 |
C |
p.
|
article
|
| 33 |
Influence of statin potency and liposolubility on Alzheimer’s disease patients: A population-based study
|
García-Zamora, Mar
|
|
|
209 |
C |
p.
|
article
|
| 34 |
Insight of neonicotinoid insecticides: Exploring exposure, mechanisms in non-target organisms, and removal technologies
|
Zhang, Yuanyuan
|
|
|
209 |
C |
p.
|
article
|
| 35 |
IUPHAR editorial: Emerging targets for the treatment of pain: Moving towards non-addicting therapeutics and new preclinical directions
|
Barrett, James E.
|
|
|
209 |
C |
p.
|
article
|
| 36 |
Kallikrein inhibitor derived from immunoglobulin heavy chain junction region possesses anti-thromboinflammation potential
|
Yang, Juan
|
|
|
209 |
C |
p.
|
article
|
| 37 |
Melatonin increases Olaparib sensitivity and suppresses cancer-associated fibroblast infiltration via suppressing the LAMB3-CXCL2 axis in TNBC
|
Lai, Yi-Wen
|
|
|
209 |
C |
p.
|
article
|
| 38 |
Microglia-mediated neuron death requires TNF and is exacerbated by mutant Huntingtin
|
Young, Alexander P.
|
|
|
209 |
C |
p.
|
article
|
| 39 |
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways
|
Stachowicz, Aneta
|
|
|
209 |
C |
p.
|
article
|
| 40 |
Molecular mechanisms underlying hepatoprotective activity of lutein in the context of intestinal failure-associated liver disease
|
Żółnowska, Izabela
|
|
|
209 |
C |
p.
|
article
|
| 41 |
Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the science
|
Breault, Émile
|
|
|
209 |
C |
p.
|
article
|
| 42 |
New insights in the mechanisms of opioid analgesia and tolerance: Ultramicronized palmitoylethanolamide down-modulates vascular endothelial growth factor-A in the nervous system
|
Micheli, Laura
|
|
|
209 |
C |
p.
|
article
|
| 43 |
New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?
|
Campagnoli, Lucrezia Irene Maria
|
|
|
209 |
C |
p.
|
article
|
| 44 |
Novel deoxyhypusine synthase (DHPS) inhibitors target hypusination-induced vasculogenic mimicry (VM) against malignant melanoma
|
Zhao, Xi-he
|
|
|
209 |
C |
p.
|
article
|
| 45 |
Online ligand screening for cytochrome C from herbal medicines through “four-in-one” measurement
|
Li, Ting
|
|
|
209 |
C |
p.
|
article
|
| 46 |
Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke
|
Jing, Kai
|
|
|
209 |
C |
p.
|
article
|
| 47 |
Overcoming limitations and advancing the therapeutic potential of antibody-oligonucleotide conjugates (AOCs): Current status and future perspectives
|
Jiao, Jinlan
|
|
|
209 |
C |
p.
|
article
|
| 48 |
Palmatine protects against atherosclerosis by gut microbiota and phenylalanine metabolism
|
Wang, Anlu
|
|
|
209 |
C |
p.
|
article
|
| 49 |
Profiling the impact of anti-human CD20 monoclonal antibodies on lymphocyte B cell subsets and their precursors in the bone marrow and in lymphoid tissues in an immunocompromised mouse engrafted with human cells
|
Moregola, Annalisa
|
|
|
209 |
C |
p.
|
article
|
| 50 |
Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales
|
Bondarev, Andrey D.
|
|
|
209 |
C |
p.
|
article
|
| 51 |
Regulation of microglia inflammation and oligodendrocyte demyelination by Engeletin via the TLR4/RRP9/NF-κB pathway after spinal cord injury
|
Chen, Wang
|
|
|
209 |
C |
p.
|
article
|
| 52 |
Revisiting the nature and pharmacodynamics of tacrolimus metabolites
|
Mevizou, Rudy
|
|
|
209 |
C |
p.
|
article
|
| 53 |
Suppression of ZEB1 by Ethyl caffeate attenuates renal fibrosis via switching glycolytic reprogramming
|
Hu, Jia-Qin
|
|
|
209 |
C |
p.
|
article
|
| 54 |
Targeted and cytotoxic inhibitors used in the treatment of lung cancers
|
Roskoski Jr., Robert
|
|
|
209 |
C |
p.
|
article
|
| 55 |
Targeting leptin/CCL3-CCL4 axes in NAFLD/MAFLD: A novel role for BPF in counteracting thalamic inflammation and white matter degeneration
|
Cardamone, Antonio
|
|
|
209 |
C |
p.
|
article
|
| 56 |
Targeting the autoreactive CD8+ T-cell receptor in type 1 diabetes: Insights from scRNA-seq for immunotherapy
|
Lai, Xiaoyang
|
|
|
209 |
C |
p.
|
article
|
| 57 |
The PINK1/Parkin signaling pathway-mediated mitophagy: a forgotten protagonist in myocardial ischemia/reperfusion injury
|
Zhao, Xiaopeng
|
|
|
209 |
C |
p.
|
article
|
| 58 |
The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health
|
Qiao, Lei
|
|
|
209 |
C |
p.
|
article
|
| 59 |
Therapeutic peptides in the treatment of digestive inflammation: Current advances and future prospects
|
He, Liangliang
|
|
|
209 |
C |
p.
|
article
|
| 60 |
The role of Tim-3 blockade in the tumor immune microenvironment beyond T cells
|
Zhang, Jie
|
|
|
209 |
C |
p.
|
article
|
| 61 |
The therapeutic potential of bee venom-derived Apamin and Melittin conjugates in cancer treatment: A systematic review
|
Laurindo, Lucas Fornari
|
|
|
209 |
C |
p.
|
article
|
| 62 |
The ZDHHC13/ZDHHC17 subfamily: From biological functions to therapeutic targets of diseases
|
Zhang, Ying
|
|
|
209 |
C |
p.
|
article
|
| 63 |
Tissue Kallikrein supplementation in ischemic phase protects the neurovascular unit and attenuates reperfusion-induced injury in ischemic stroke
|
Ran, Xiao
|
|
|
209 |
C |
p.
|
article
|
| 64 |
TRP channels in cancer: Therapeutic opportunities and research strategies
|
Xu, Jiahui
|
|
|
209 |
C |
p.
|
article
|
| 65 |
Type 2 diabetes mellitus and neurodegenerative disorders: The mitochondrial connection
|
Baduini, Isabella R.
|
|
|
209 |
C |
p.
|
article
|
| 66 |
USP9X-enriched MSC-sEV inhibits LSEC angiogenesis in MASH mice by downregulating the IκBα/NF-κB/Ang-2 pathway
|
Wang, Yanjin
|
|
|
209 |
C |
p.
|
article
|
Journal description